New eye drops aim to soothe dry eyes for thousands
NCT ID NCT07457021
First seen Mar 09, 2026 · Last updated May 15, 2026 · Updated 11 times
Summary
This study will test an eye drop called perfluorohexyloctane, already approved in China for dry eye disease caused by meibomian gland dysfunction. Researchers will watch 2000 adults in real-world clinics to see how safe and helpful the drops are, alone or with other treatments. The goal is to ease symptoms like dryness and burning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xiamen Eye Center Affiliated to Xiamen University
Xiamen, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.